The clinical and prognostic value of FAM57A expression was then analyzed, and multiple enrichment analyses were performed to investigate the potential molecular mechanisms that could be mediated by FAM57A in HCC. The gene discussed is TLCD3A; the disease is hepatocellular carcinoma.